Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

228

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

228 results for “Immunotherapy targets”

Learn how ShareScore rates datasets ↗
geo20/100

Immunotherapy Targets in Tumors

GEO Series GSE53388. Mus musculus. 36 samples. Type: Expression profiling by array.

openGEO-OpenMar 2014View details →
geo20/100

Systematic identification of immunotherapy targets using genome-scale in vivo CRISPR screens in CD8+ cytotoxic T cells

GEO Series GSE132960. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2019View details →
geo20/100

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants

GEO Series GSE296471. Homo sapiens. 1 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMay 2025View details →
geo20/100

Targeting Vdac2 overcomes immunotherapy resistance by inducing tumor cell death and inflammation [microarray 2]

GEO Series GSE261546. Mus musculus. 40 samples. Type: Expression profiling by array.

openGEO-OpenMar 2025View details →
ClinicalTrials.gov20/100

Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer

ClinicalTrials.gov study NCT07009600. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

ClinicalTrials.gov study NCT07309419. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

ClinicalTrials.gov study NCT03818997. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma

ClinicalTrials.gov study NCT06364787. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma

ClinicalTrials.gov study NCT06132438. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

ClinicalTrials.gov study NCT06364800. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

ClinicalTrials.gov study NCT07039474. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
geo20/100

Targeting Vdac2 overcomes immunotherapy resistance by inducing tumor cell death and inflammation [microarray 4]

GEO Series GSE261549. Mus musculus. 36 samples. Type: Expression profiling by array.

openGEO-OpenMar 2025View details →
geo20/100

RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy

GEO Series GSE233808. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing; Methylation profiling by high throughput sequencing.

openGEO-OpenAug 2023View details →
geo20/100

Siglec-G suppresses CD8+ T cells responses through metabolic rewiring and can be targeted to enhance tumor immunotherapy

GEO Series GSE272544. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2024View details →
geo20/100

RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy [m6A-seq]

GEO Series GSE233807. Homo sapiens. 8 samples. Type: Methylation profiling by high throughput sequencing.

openGEO-OpenAug 2023View details →
geo16/100

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.

GEO Series GSE52756. Homo sapiens. 40 samples. Type: Expression profiling by RT-PCR.

openGEO-OpenNov 2016View details →
geo16/100

Targeting YAP/TEAD signaling disturbs RNA Pol II activity and enhances immunotherapy response via activated cytosolic DNA sensing pathway in gastroesophageal cancer

GEO Series GSE316491. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2026View details →
geo16/100

Pseudouridine Synthesis Targeted Therapy Activates Antiviral Immunity to Boost Cancer Immunotherapy

GEO Series GSE303223. Mus musculus. 20 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJul 2025View details →
geo16/100

Dual-Targeted Ping-Pong CAR T Cells: Leveraging Peripheral Expansion to Improve Solid Tumor Immunotherapy

GEO Series GSE307863. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2025View details →
geo16/100

Targeting KRASG12V mutations with HLA class II restricted TCR for the immunotherapy in solid tumors

GEO Series GSE232897. Homo sapiens. 3 samples. Type: Expression profiling by high throughput sequencing; Other.

openGEO-OpenMay 2023View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.